Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious complications in liver transplantation.

J O Colonna1, D J Winston, J E Brill

  • 1Department of Surgery, UCLA-Center for the Health Sciences 90024.

Archives of Surgery (Chicago, Ill. : 1960)
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Liver transplantation in recipients receiving renal replacement therapy: outcomes analysis and the role of intraoperative hemodialysis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency.

Bone marrow transplantation·2010
Same author

Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.

Transplantation proceedings·2007
Same author

Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006

Liver transplant recipients frequently experience infections, with 66% of patients developing complications. Early diagnosis and treatment are crucial for managing these serious post-transplant infections.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Infectious Diseases

Background:

  • Liver transplantation is a complex procedure with significant risks.
  • Post-transplant infections remain a major challenge in patient outcomes.
  • Advances in surgical techniques and immunosuppression have not eliminated infection risks.

Purpose of the Study:

  • To analyze the incidence, types, and outcomes of infections following orthotopic liver transplantation.
  • To identify the common pathogens and their onset timing post-transplant.
  • To underscore the significance of infection as a cause of mortality.

Main Methods:

  • Retrospective analysis of 35 patients who underwent 42 liver homografts between February 1984 and August 1985.
  • Categorization and tracking of bacterial, viral, and fungal infections.

Related Experiment Videos

  • Assessment of infection-related mortality.

    • Main Results:

    • 66% of patients (23/35) developed one or more infections post-transplantation.
    • An average of 2.5 infections per infected patient was observed.
    • Bacterial infections (bacteremias, intra-abdominal) had a median onset of 29 days; viral infections at 18 days; fungal infections at 9 days.
    • Infection was the primary cause of death in 14% (5/35) of patients, with fatal infections distributed among bacterial, fungal, and viral pathogens.

    Conclusions:

    • Infection remains a serious complication after orthotopic liver transplantation, despite advancements.
    • Identifying high-risk patients for aggressive workup and early antimicrobial therapy is essential.
    • Proactive management strategies are necessary to mitigate infection-related morbidity and mortality.